Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
===============================================================================================================================================================================================

* Sophia Stock
* Mohamed-Reda Benmebarek
* Anna-Kristina Kluever
* Diana Darowski
* Christian Jost
* Kay-Gunnar Stubenrauch
* Joerg Benz
* Anne Freimoser-Grundschober
* Ekkehard Moessner
* Pablo Umana
* Marion Subklewe
* Stefan Endres
* Christian Klein
* Sebastian Kobold